Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04658589 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Laparoscopic vs. Open Distal Gastrectomy After Neoadjuvant Chemotherapy

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 8, 2020 (before its estimated December 2023 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The study was designed as single-country, multi-center, open-labelled, randomized (1:1), phase II trial. 238 patients with medically and technically operable advanced gastric adenocarcinoma in middle or distal 1/3 of stomach are enrolled and randomly assigned to laparoscopic gastrectomy group and open gastrectomy group. 4 cycles of mFLOT chemotherapy will be conducted before and after gastrectomy. The primary objective of this study is comparison of D2 lymph node dissection compliance rate between open surgery group and laparoscopic surgery group after neoadjuvant chemotherapy.
Trial Details
NCT Number NCT04658589
Lead Sponsor Chonnam National University Hospital
Conditions
(from sponsor)		 Stomach Neoplasm
Related terms Stomach Neoplasms
Enrollment 238 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov